NewAmsterdam Pharma Company N.V. Ordinary Shares NAMS
$22.58
-0.70%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $47.43
- Implied Upside
- +110.0%
- Price Target Range
- $37.00 – $52.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-08 | HC Wainwright & Co.Lander Egaña Gorroño |
Reiterates | Buy | $52 |
| 2026-08-06 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $51 → $50 |
| 2026-06-30 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $47 → $51 |
| 2026-02-19 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $41 → $45 |
| 2026-02-18 | NeedhamSerge Belanger |
Maintains | Buy | $46 → $48 |
| 2026-01-21 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $44 → $47 |
| 2025-12-16 | StifelJames Condulis |
Maintains | Buy | $44 → $50 |
| 2025-12-02 | Goldman SachsAsad Haider |
Maintains | Neutral | $30 → $37 |
| 2025-11-06 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $39 → $44 |
| 2025-11-05 | NeedhamSerge Belanger |
Maintains | Buy | $40 → $46 |
| 2025-10-20 | HC Wainwright & Co.Joseph Pantginis |
Assumes | Buy | $52 |
| 2025-10-17 | CitigroupGeoff Meacham |
Maintains | Buy | $42 → $50 |
| 2025-08-25 | Wells FargoYanan Zhu |
Initiates coverage on | Overweight | $45 |
| 2025-08-07 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $38 → $39 |
| 2025-07-17 | Goldman SachsAsad Haider |
Initiates coverage on | Neutral | $27 |
| 2025-06-17 | CitigroupGeoff Meacham |
Initiates coverage on | Buy | $42 |
| 2025-06-12 | NeedhamSerge Belanger |
Reiterates | Buy | $40 |
| 2025-06-10 | StifelJames Condulis |
Initiates coverage on | Buy | $44 |
| 2025-05-08 | NeedhamSerge Belanger |
Maintains | Buy | $42 → $40 |
| 2025-04-08 | NeedhamSerge Belanger |
Reiterates | Buy | $42 |
| 2025-02-27 | ScotiabankGeorge Farmer |
Maintains | Sector outperform | $47 → $52 |
| 2025-02-27 | NeedhamSerge Belanger |
Maintains | Buy | $46 → $42 |
| 2025-01-28 | RBC CapitalBrian Abrahams |
Reiterates | Outperform | $40 |
| 2025-01-24 | RBC CapitalLeonid Timashev |
Reiterates | Outperform | $40 |
| 2025-01-14 | HC Wainwright & Co.Ed Arce |
Reiterates | Buy | $48 |
| 2024-12-30 | HC Wainwright & Co.Ed Arce |
Initiates coverage on | Buy | $48 |
| 2024-12-11 | ScotiabankGeorge Farmer |
Maintains | Sector outperform | $35 → $47 |
| 2024-12-05 | NeedhamSerge Belanger |
Reiterates | Buy | $36 |
| 2024-11-21 | NeedhamSerge Belanger |
Reiterates | Buy | $36 |
| 2024-11-11 | NeedhamSerge Belanger |
Reiterates | Buy | $36 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $22.58
- Market Cap
- $2.70 billion
- 52-Week Range
- $21.02 – $42.20
- Average Volume
- 1.52 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.